geniposide has been researched along with Cardiomegaly in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kong, CY; Ma, ZG; Song, P; Tang, QZ; Yuan, YP; Zhang, X | 1 |
Bian, ZY; Dai, J; Liao, HH; Ma, ZG; Tang, QZ; Yuan, Y; Zhang, N; Zhang, WB | 1 |
2 other study(ies) available for geniposide and Cardiomegaly
Article | Year |
---|---|
Geniposide Protects against Obesity-Related Cardiac Injury through AMPK
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cardiomegaly; Diet, High-Fat; Heart; Inflammation; Iridoids; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Signal Transduction; Sirtuin 1 | 2018 |
Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Activation; Glucagon-Like Peptide 1; Iridoids; Male; Mice; Mice, Inbred C57BL; Signal Transduction; Structure-Activity Relationship | 2016 |